Cover Image
市場調查報告書

過敏診斷、治療的全球市場:市場機會、市場佔有率、市場規模分析、預測

Global Allergy Diagnostics and Treatments Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 360998
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
過敏診斷、治療的全球市場:市場機會、市場佔有率、市場規模分析、預測 Global Allergy Diagnostics and Treatments Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年06月11日 內容資訊: 英文 140 Pages
簡介

全球過敏診斷、治療的市場,預計從2016年到2022年以12.67%的年複合成長率 (CAGR) 成長。過敏疾病的增加,IVD市場擴大,醫療費的增加,實驗室自動化的擴大等要素促進該市場的成長。

本報告提供全球過敏診斷、治療的的市場調查分析,市場定義和概要,市場背景,市場的各種影響因素分析,競爭環境與市場佔有率,成長地區、成長部門分析,各過敏類型、產品區分、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,以及主要企業的簡介等彙整。

第1章 簡介

第2章 市場概要

  • 市場定義、範圍
  • 主要調查結果
  • 參數放行
  • 市場分析
    • 新興國家前3名
    • 收益生成部門前3名
    • 主要的成長市場、新興趨勢
    • 前3名地區
  • 競爭環境
    • 市場佔有率分析
    • 主要成功策略
    • 案例研究
  • 波特的五力分析
  • 主要的購買標準
  • 策略性建議
  • 策略性總論

第3章 市場影響因素

  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場分析:各種類

  • 市場預測:各類型
    • 食品過敏
    • 吸入過敏
    • 其他
  • 市場預測:各產品
    • 化驗套件
    • 消耗品
    • 設備
  • 市場預測:各終端用戶
    • 學術研究機關
    • 診斷實驗室
    • 醫院
    • 其他

第5章 地區市場預測

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 其他
  • 亞洲
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 其他地區
    • 南美
    • 中東、北非
    • 非洲

第6章 企業簡介

  • ALCON LABORATORIES
  • ALCON LABORATORIES, INC.
  • ALLERCHECK, INC.
  • BIOMERIEUX
  • DANAHER CORPORATION
  • HITACHI CHEMICAL DIAGNOSTICS
  • HOB BIOTECH GROUP
  • HYCOR BIOMEDICAL
  • LINCOLN DIAGNOSTICS
  • NIDEC CORP
  • OMEGA DIAGNOSTICS
  • SANOFI S.A
  • SIEMENS HEALTHCARE
  • STALLERGENES
  • THERMO FISHER SCIENTIFIC

圖表

目錄
Product Code: HME-1491015

The global allergy diagnostics and treatment market is expected to grow with CAGR of 12.67% in the forecasted period of 2016-2022. The key factors driving the global allergy diagnostics and treatments market are increasing allergies diseases, increasing IVD markets, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergies cases day by day is ultimately increasing the market of allergy diagnostics and treatments. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. The increasing allergy cases in developing region is the key opportunity to drive the market of allergy diagnostics and treatments. The developing regions such as India, China has been on an uprising trend in terms of severity as well as prevalence. These allergic diseases contains asthma, rhinitis, anaphylaxis, drug, food and insect allergy and many more. Approx. 20% to 30 % of the total population suffers from at least one of these allergic diseases in India in which 20% to 30% of the population suffer from allergic rhinitis and that 15% develop asthma. Thus the increasing cases of allergy is driving the market of allergy diagnostic and treatment in India.

The market is majorly segmented on the basis of types, product and end users. On the basis of types, the market is further segmented as food, inhaled and others. On the product basis, the market is further segmented as assay kits, consumables and instruments. On the basis of end users the market is further segmented as academic research centers, diagnostic laboratories, hospitals and other users. Hospitals are the largest consumers of allergy diagnostic products. It is expected that this segment will accelerate with CAGR of over 11% in future years.

Based on types, product and end users the market is regionally segmented into North America, Europe, Asia Pacific and Rest of the world. North America holds the largest market share of allergy diagnostics and treatments and is followed by Europe. High technology and high investments in medical sector is promoting the growth of market. Moreover, every thirteen children having age of 18 years in U.S. is suffering from one or the other allergic problems. There are more than 17 million cases of food allergy in Europe and there have been seven times rise among children over the past decades.

Some of the major market players are Allercheck Laboratories, Inc., BioMerieux SA, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., Omega Diagnostics Group plc. HOB Biotech Group Co., Ltd., HYCOR BioMedical, Lincoln Diagnostics, Inc., Siemens Healthcare, Stallergenes, and Thermo Fisher Scientific, Inc.. Acquisitions, merger and novel technology are the key strategies adopted by the market players to sustain in the market. As MeDALL allergen chip is used to determine allergies which helps to increase allergy diagnostics and treatments market globally. In Japan, in 2015 Stallergenes received approval for STG 320 which is the first tablet used in the treatment of house dust mite allergy.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
    • 2.3.1. RAW MATERIAL SUPPLIER
    • 2.3.2. PRODUCTION GEOGRAPHICALLY
    • 2.3.3. ADOPTION ACROSS VARIOUS INDUSTRIES
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP 3 EMERGING COUNTRIES
    • 2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. TOP 3 GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING ALLERGIES DISEASES
    • 3.1.2. GROWING IVD MARKET
    • 3.1.3. INCREASING HEALTHCARE EXPENDITURE GROW THE MARKET
    • 3.1.4. INCREASING LABORATORY AUTOMATION
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. HIGH CAPITAL INVESTMENT
    • 3.2.2. STRICT REGULATION POLICIES FOR MEDICAL DEVICES
    • 3.2.3. HIGH DEGREE OF FORTIFICATION ACT AS ENTRY BARRIER
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. INCREASING OPPORTUNITIES IN DEVELOPING COUNTRIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF BUDGET IS A GREAT CHALLENGE FOR MARKET GROWTH
    • 3.4.2. HIGH TURNAROUND TIME
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. BY TYPE
    • 4.1.1. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY FOOD 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY INHALED 2014-2022 ($ MILLION)
    • 4.1.3. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 4.2. BY PRODUCT
    • 4.2.1. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY ASSAY KITS 2014-2022 ($ MILLION)
    • 4.2.2. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY CONSUMABLES 2014-2022 ( $ MILLION)
    • 4.2.3. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY INSTRUMENTS 2014-2022 $ MILLION)
  • 4.3. BY END USERS
    • 4.3.1. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY ACADEMIC RESEARCH CENTERS 2014-2022 ($ MILLION)
    • 4.3.2. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY DIAGNOSTIC LABORATORIES 2014-2022 ($ MILLION)
    • 4.3.3. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY HOSPITALS, 2014-2022 ($ MILLION)
    • 4.3.4. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY OTHER END USERS 2014-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.4. KOREA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.5. AUSTRALIA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.3.6. ROAPAC ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA ALLERGY DIAGNOSTICS AND TREATMENT MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILE

  • 1. ALCON LABORATORIES
  • 2. ALCON LABORATORIES, INC.
  • 3. ALLERCHECK, INC.
  • 4. BIOMERIEUX
  • 5. DANAHER CORPORATION
  • 6. HITACHI CHEMICAL DIAGNOSTICS
  • 7. HOB BIOTECH GROUP
  • 8. HYCOR BIOMEDICAL
  • 9. LINCOLN DIAGNOSTICS
  • 10. NIDEC CORP
  • 11. OMEGA DIAGNOSTICS
  • 12. SANOFI S.A
  • 13. SIEMENS HEALTHCARE
  • 14. STALLERGENES
  • 15. THERMO FISHER SCIENTIFIC

LIST OF TABLES

  • 1. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY TYPE 2014-2022 ($ MILLION)
  • 2. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY FOOD 2014-2022 ($ MILLION)
  • 3. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY INHALED 2014-2022 ($ MILLION)
  • 4. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 5. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY PRODUCT 2014-2022 ($ MILLION)
  • 6. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY ASSAY KITS 2014-2022($ MILLION)
  • 7. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY CONSUMABLES 2014-2022($ MILLION)
  • 8. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY INSTRUMENTS 2014-2022($ MILLION)
  • 9. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY END USERS 2014-2022 ($ MILLION)
  • 10. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY ACADEMIC RESEARCH CENTERS 2014-2022 ($ MILLION)
  • 11. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY DIAGNOSTIC LABORATORIES 2014-2022 ($ MILLION)
  • 12. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY HOSPITALS 2014-2022 ($ MILLION)
  • 13. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY OTHER END USERS 2014-2022($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY TYPE 2014-2022 ($ MILLION)
  • 2. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY FOOD 2014-2022 ($ MILLION)
  • 3. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY INHALED 2014-2022 ($ MILLION)
  • 4. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY OTHERS 2014-2022 ($ MILLION)
  • 5. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENTS MARKET BY PRODUCT 2014-2022 ($ MILLION)
  • 6. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY ASSAY KITS 2014-2022 ($ MILLION)
  • 7. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY CONSUMABLES 2014-2022 ($ MILLION)
  • 8. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY INSTRUMENTS 2014-2022 ($ MILLION)
  • 9. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY END USERS 2014-2022 ($ MILLION)
  • 10. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY ACADEMIC RESEARCH CENTERS 2014-2022 ($ MILLION)
  • 11. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY DIAGNOSTIC LABORATORIES 2014-2022 ($ MILLION)
  • 12. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY HOSPITALS 2014-2022 ($ MILLION)
  • 13. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET BY OTHER END USERS 2014-2022 ($ MILLION)
Back to Top